With Pennsylvania’s budget deadline looming, Governor Josh Shapiro says he’s optimistic that lawmakers can still come together on a marijuana legalization plan. In a press conference held today, Shapiro called on Senate Republicans to bring forward their own version after the chamber rejected a legalization bill passed by the House. “We’ve had really good, honest …
Category: News
Latest cannabis news covering legalization, legislation, court rulings, business developments, research, sales data, regulatory updates and policy changes across the U.S.
Maine House Approves Psilocybin (Magic Mushroom) Decriminalization Bill in 70 to 69 Vote
The Maine House of Representatives has narrowly approved legislation that would decriminalize the possession of small amounts of psilocybin, passing the measure by a single vote, 70 to 69. House Bill 1034, backed by a bipartisan coalition of nine lawmakers, would eliminate criminal penalties for adults 21 and older who possess up to one gram …
Massachusetts Cannabis Reform Bill Approved by House Ways and Means Committee, Full House Vote Set for Wednesday
Legislation to reform Massachusetts’ cannabis laws cleared a key hurdle today in the Massachusetts Legislature, gaining approval from the House Ways and Means Committee. The measure, House Bill 4160—titled An Act Modernizing the Commonwealth’s Cannabis Laws—is now scheduled for a full vote on the House floor tomorrow, June 4. The legislation represents one of the …
DEA Faces Accusations of Corruption, Constitutional Violations, and Cannabis Bias
The Drug Enforcement Administration is under growing scrutiny for alleged ethical violations, constitutional defiance, and obstruction of marijuana research, prompting calls for mass terminations, agency reform, and congressional intervention. At the center of the controversy is DEA attorney Aarathi Haig, who is spearheading the agency’s case against MMJ BioPharma Cultivation despite being listed as ineligible …
Ohio’s Recreational Cannabis Purchase Limits to Increase Starting Tomorrow, June 4
Starting tomorrow, June 4, Ohio will officially raise the daily purchase limits for recreational marijuana products, according to the state’s Division of Cannabis Control. Under the new rules, those 21 and older will be allowed to purchase up to 2.5 ounces of cannabis flower per day, a notable increase from the previous limit of 2.5 …
CBD Life Sciences Releases New CBD Suppositories for Vaginal and Rectal Relief
CBD Life Sciences Inc. (CBDL) has entered the $2.8 billion global suppository market with the launch of its new line of CBD-infused vaginal and rectal suppositories, offering consumers an alternative delivery method for fast-acting, localized relief. The Arizona-based company says its new products provide a unique approach to addressing issues such as menstrual cramps, endometriosis, …
Study: Cannabis-Based Treatments Associated With Seizure Freedom in Drug-Resistant Epilepsy Patients
A new case series published in the journal Frontiers in Neuroscience details how cannabis-based products led to seizure freedom in nearly a dozen pediatric and adult patients with drug-resistant epilepsy (DRE). Conducted by researchers at the University of Toronto and University Health Network, the retrospective study evaluated 19 patients with DRE—15 of them children—who experienced …
CNBC’s Jim Cramer Calls Aurora Cannabis “a Nice Speculative Stock”
During a recent segment of CNBC’s Mad Money, host Jim Cramer gave a cautiously optimistic take on Aurora Cannabis, calling it “a nice speculative stock.” Cramer made the comments in response to a viewer named Eric from New York, who called in saying: “My question, ECB Aurora Cannabis.” Cramer replied: “You know I keep thinking …
California Assembly Unanimously Passes Bill to Delay Marijuana Excise Tax Increase
The California Assembly has unanimously passed legislation to delay a planned increase in the state’s cannabis excise tax. Introduced by Assemblymember Matt Haney, Assembly Bill 564 would postpone scheduled changes to the state’s marijuana excise tax until the 2030–31 fiscal year. The proposal was passed by the Assembly 74 to 0, sending it to the …
Study: Combination of CBD and Hydroxychloroquine Found Safe and Bioavailable in Phase I Trial
A phase I clinical trial has found that a novel combination of cannabidiol (CBD) and hydroxychloroquine (HCQ), known as IHL-675 A, is well tolerated and bioavailable in healthy volunteers, supporting further investigation in inflammatory conditions such as rheumatoid arthritis. The trial involved 36 participants who were randomly assigned to receive either IHL-675 A, Epidiolex (CBD), …













